🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
SymBio Pharmaceuticals Limited (TYO:4582)
Japan flag Japan · Delayed Price · Currency is JPY
69.00
-9.00 (-11.54%)
Nov 20, 2026, 3:30 PM JST

SymBio Pharmaceuticals Revenue

SymBio Pharmaceuticals had revenue of 252.14M JPY in the quarter ending September 30, 2026, a decrease of -22.22%. This brings the company's total for the last twelve months to 1.06B, down -30.58% year-over-year. In the year 2025, SymBio Pharmaceuticals had annual revenue of 1.31B, down -46.70%. That makes SymBio Pharmaceuticals the 39,006th largest company in the world by revenue and 3,785th in Japan.

Revenue (ttm)
1.06B
Revenue Growth
-30.58%
P/S Ratio
5.50
Revenue / Employee
11.64M
Employees
91
Market Cap
5.83B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.31B-1.15B-46.70%
Dec 31, 20242.45B-3.14B-56.13%
Dec 31, 20235.59B-4.42B-44.15%
Dec 31, 202210.01B1.75B21.21%
Dec 31, 20218.26B5.27B176.42%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.